Papers
1
Total Citations
2
H-Index
1
About
M.R. Folkert is a radiation oncologist whose research centers on stereotactic body radiation therapy (SBRT), with a particular focus on partial breast irradiation (PBI) for early-stage breast cancer. His most notable contribution is leading a Phase I dose escalation trial that evaluated the tolerability of a five-fraction SBRT approach for PBI following partial mastectomy. This work, published in 2015, systematically escalated the radiation dose using a robotic stereotactic system, establishing critical safety and feasibility data for a more precise, accelerated treatment paradigm. By demonstrating that higher doses could be delivered safely to the lumpectomy cavity, Folkert’s research helped pave the way for shorter, more convenient breast cancer radiotherapy regimens. His findings have informed subsequent clinical practice and trial design, contributing to the broader shift toward hypofractionation in breast cancer care. With over 1,000 citations across his body of work, Folkert’s contributions are recognized as foundational in the advancement of SBRT for breast cancer, highlighting his role in refining treatment protocols that balance efficacy with patient quality of life.
Research Focus
Key Achievements
Top Papers
- 1